Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
| Field | Value | Language |
| dc.contributor.author | Flitcroft, K | |
| dc.contributor.author | Irwig, LM | |
| dc.contributor.author | Carter, SM | |
| dc.contributor.author | Salkeld, G | |
| dc.contributor.author | Gillespie, James | |
| dc.date.accessioned | 2014-07-07 | |
| dc.date.available | 2014-07-07 | |
| dc.date.issued | 2012-01-01 | |
| dc.identifier.citation | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology 2012 12:183 | en |
| dc.identifier.uri | http://www.biomedcentral.com/1471-230X/12/183 | |
| dc.identifier.uri | http://hdl.handle.net/2123/11466 | |
| dc.description.abstract | Abstract Background:There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening. Discussion:While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening. Summary:Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives. Keywords:Screening objectives, Colorectal cancer, Fecal occult blood testing, Harm minimization, Equity, Economic efficiency, Prevention, Participation | en |
| dc.language.iso | en_AU | en |
| dc.publisher | BMC | en |
| dc.rights | Creative Commons Attribution 4.0 | en |
| dc.subject | Screening objectives | en |
| dc.subject | Colorectal cancer | en |
| dc.subject | Fecal occult blood testing | en |
| dc.subject | Harm minimization | en |
| dc.subject | Equity | en |
| dc.subject | Economic efficiency | en |
| dc.subject | Prevention | en |
| dc.subject | Participation | en |
| dc.title | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option | en |
| dc.type | Article | en |
| usyd.faculty | SeS faculties schools::Faculty of Medicine and Health::Sydney Health Ethics | en |
Associated file/s
Associated collections